MedAdvisor glaucoma pact
August 16, 2016
LISTED medication adherence
company MedAdvisor has
announced a new partnership with
Glaucoma Australia, which will see
the peak patient support group
promote the MedAdvisor platform
to the over 300,000 Australians
estimated to have glaucoma.
The collaboration will see
Glaucoma Australia become a
MedAdvisor Health Association
Partner, with the company also
to collaborate on a series of
patient education messages to
be delivered via the MedAdvisor
platform to improve compliance
and understanding of the condition.
“Working collaboratively with
key health associations, such
as Glaucoma Australia, is one
of the most effective ways that
we can expand the reach of the
MedAdvisor platform to help more
Australians improve their health
through medication adherence,”
said MedAdvisor ceo Robert Read.
“We know that improvement in
medication adherence can lead to
better health outcomes, such as
delaying the onset of vision loss”.
Glaucoma is the leading cause of
irreversible blindness worldwide,
and affects one in eight Australians
over the age of 80.
MedAdvisor’s Glaucoma Australia
partnership sees the organisation
join other members of the
Health Partner Network including
Bupa, Epilepsy Queensland and
Painaustralia, with the network “an
important source of registrations
for MedAdvisor as it provides third
party validation from recognised
and credible organisations”.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Aug 16To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Aug 16
